SCHEMBL7044536

SCHEMBL7044536

CC(C)(Oc1ccc(NCCCCOc2ccc3c(-c4ccccc4)noc3c2CC2CC2)cc1)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 20/20 0.65
PPARG P37231 19/20 0.65
PPARD Q03181 19/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7038835 0.74 PPARA (0.48) PPARAPPARGPPARD
SCHEMBL7037974 0.74 PPARA (0.82) PPARAPPARGPPARD
SCHEMBL7041586 0.72 PPARG (0.69) PPARAPPARGPPARD
SCHEMBL7041507 0.71 PPARG (0.78) PPARAPPARGPPARD
SCHEMBL5992549 0.68 PPARA (0.78) PPARAPPARGPPARD
SCHEMBL8006414 0.68 PPARG (0.70) PPARAPPARGPPARD
SCHEMBL7043976 0.67 PPARA (0.96) PPARAPPARGPPARD
SCHEMBL7044780 0.67 PPARG (0.78) PPARAPPARGPPARD
SCHEMBL7041214 0.66 PPARA (0.39) PPARAPPARGPPARD
SCHEMBL6939104 0.65 PPARG (0.69) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP claimed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US claimed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP claimed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO claimed
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed